Introduction by the President of the National Health Fund hanges the accounting for contract drug had on healthcare providers need for a change in the method of accounting used drugs. In connection with the necessity of a detailed accounting of drugs raised questions related to the excess of the drug in an ampoule on the other hand the necessity of accounting for only the amount of drug consumed and the lack of reimbursement for the so-called. drug utilization. The challenge of recent times for entities that have contracts with the NFZ agreement to chemotherapy or drug programs has become the number of mg of the drug in an ampoule and develop appropriate methods of dealing with the additional amount. The issue of unregulated legal writing has become a cause of many doubts as to the treatment of surpluses and the proper accounting of drugs given to patients.

Key words: benefits, settlements, chemotherapy, drugs, dose, drug utylization.